DARGAN CHARLES K 4
4 · BIOLARGO, INC. · Filed Aug 15, 2024
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
DARGAN CHARLES K
Chief Financial Officer
Transactions
- Award
Option
2024-08-13+300,000→ 4,625,786 totalExercise: $0.24From: 2024-08-13Exp: 2034-08-13→ common stock (300,000 underlying)
Footnotes (2)
- [F1]The Option vests in equal monthly installments of 25,000 shares, so long as the Engagement Extension Agreement dated August 13, 2024, between Reporting Person and Issuer, remains in force and effect.
- [F2]This Option was issued to the Reporting Person as compensation to serve as Issuer's Chief Financial Officer from February 1, 2024, through January 31, 2025.